Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1971 Jul;42(3):343–351. doi: 10.1111/j.1476-5381.1971.tb07118.x

3,4-Dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum

A reflection of intra- and extra-neuronal metabolism of dopamine?

Suzanne Roffler-Tarlov, D F Sharman, P Tegerdine
PMCID: PMC1665655  PMID: 5560896

Abstract

1. The administration of probenecid to mice increased the concentration of 4-hydroxy-3-methoxyphenylacetic acid (HVA) in the striatum, but did not raise the concentration of 3,4-dihydroxyphenylacetic acid (DOPAC).

2. After drug treatments which normally increase the concentration of HVA several-fold, inhibition of catechol-O-methyltransferase (COMT) by tropolone greatly reduced the concentration of HVA but resulted in only a small increase in the concentration of DOPAC in the striatum of the mouse.

3. These results indicate that HVA and DOPAC do not occur at the same location in the tissue of the striatum and that DOPAC is not normally metabolized to HVA to any great extent in this tissue.

4. When mice were treated with reserpine, which is thought to prevent the intraneuronal storage of dopamine, there was an increase in the striatal concentration of DOPAC which preceded an increase in the concentration of HVA. Since non-cholinergic nerve endings of rat brain contain mitochondria and show monoamine oxidase activity, this result suggests that DOPAC is formed intraneuronally.

5. It is concluded that the DOPAC in the striatum represents intraneuronal metabolism of dopamine and that only the HVA which is sensitive to the action of probenecid represents entirely extraneuronal metabolism of this amine. Some of the HVA is not sensitive to the action of probenecid. This suggests that part of the metabolism of dopamine involved both locations.

6. A group of drugs which are chemically related to amphetamine were tested for their effects on the concentrations of DOPAC and HVA in the striatum. It is suggested that D-amphetamine, 2-aminotetralin and 1,2,3,4-tetrahydroisoquinoline reduced the intraneuronal metabolism of dopamine whereas adamantanamine did not.

Full text

PDF
343

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahtee L., Sharman D. F., Vogt M. Acid metabolites of monoamines in avian brain; effects of probenecid and reserpine. Br J Pharmacol. 1970 Jan;38(1):72–85. doi: 10.1111/j.1476-5381.1970.tb10337.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carlsson A., Lindqvist M., Dahlström A., Fuxe K., Masuoka D. Effects of the amphetamine group on intraneuronal brain amines in vivo and in vitro. J Pharm Pharmacol. 1965 Aug;17(8):521–523. doi: 10.1111/j.2042-7158.1965.tb07717.x. [DOI] [PubMed] [Google Scholar]
  3. Coyle J. T., Snyder S. H. Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different areas. J Pharmacol Exp Ther. 1969 Dec;170(2):221–231. [PubMed] [Google Scholar]
  4. Glowinski J., Axelrod J., Iversen L. L. Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther. 1966 Jul;153(1):30–41. [PubMed] [Google Scholar]
  5. Guldberg H. C., Broch O. J., Jr On the mode of action of reserpine on dopamine metabolism in the rat striatum. Eur J Pharmacol. 1971 Jan;13(2):155–167. doi: 10.1016/0014-2999(71)90146-4. [DOI] [PubMed] [Google Scholar]
  6. Juorio A. V., Sharman D. F., Trajkov T. The effect of drugs on the homovanillic acid content of the corpus striatum of some rodents. Br J Pharmacol Chemother. 1966 Feb;26(2):385–392. doi: 10.1111/j.1476-5381.1966.tb01918.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. KOPIN I. J., AXELROD J. The role of monoamine oxidase in the release and metabolism of norepinephrine. Ann N Y Acad Sci. 1963 Jul 8;107:848–855. doi: 10.1111/j.1749-6632.1963.tb13328.x. [DOI] [PubMed] [Google Scholar]
  8. KOPIN I. J., GORDON E. K. Metabolism of norepinephrine-H3 released by tyramine and reserpine. J Pharmacol Exp Ther. 1962 Dec;138:351–359. [PubMed] [Google Scholar]
  9. LAVERTY R., SHARMAN D. F. THE ESTIMATION OF SMALL QUANTITIES OF 3,4-DIHYDROXYPHENYLETHYLAMINE IN TISSUES. Br J Pharmacol Chemother. 1965 Apr;24:538–548. doi: 10.1111/j.1476-5381.1965.tb01744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Murphy G. F., Robinson D., Sharman D. F. The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse. Br J Pharmacol. 1969 May;36(1):107–115. doi: 10.1111/j.1476-5381.1969.tb08308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. RODRIGUEZ DE LORES ARNAIZ G., DE ROBERTIS E. D. Cholinergic and non-cholinergic nerve endings in the rat brain. II. Subcellular localization of monoamine oxidase and succinate dehydrogenase. J Neurochem. 1962 Sep-Oct;9:503–508. doi: 10.1111/j.1471-4159.1962.tb04203.x. [DOI] [PubMed] [Google Scholar]
  12. Rutledge C. O. The mechanisms by which amphetamine inhibits oxidative deamination of norepinephrine in brain. J Pharmacol Exp Ther. 1970 Feb;171(2):188–195. [PubMed] [Google Scholar]
  13. Sharman D. F. A discussion of the modes of action of drugs which increase the concentration of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) in the striatum of the mouse. Br J Pharmacol Chemother. 1967 Aug;30(3):620–626. doi: 10.1111/j.1476-5381.1967.tb02168.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sharman D. F. Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs. Br J Pharmacol Chemother. 1966 Nov;28(2):153–163. doi: 10.1111/j.1476-5381.1966.tb01881.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES